MedTrace Logo

HCV Treatment in a Low-threshold Clinic

NCT04063839 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2019-08-21

No results posted yet for this study

Summary

This is a cohort of people who inject drugs with chronic HCV infection. Patients are seen at a low-threshold clinic. All patients are offered treatment for HCV and subsequently followed for to years

Conditions

Interventions

DRUG

Elbasvir / Grazoprevir Oral Tablet

HCV treatment according to Norwegian guidelines

Sponsors & Collaborators

  • University Hospital, Akershus

    lead OTHER

Principal Investigators

  • Olav Dalgard, MD PhD · University Hospital, Akershus

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2019-10-31
Completion
2022-12-31
FDA Drug
Yes

Countries

  • Norway

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04063839 on ClinicalTrials.gov